Source: Annual Congress 2004 - Cardio-vascular function in OSA patients
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
K. Pagonidis, D. Tsetis, E. Lampiri, E. Argiana, N. Gourtsoyiannis, N. M. Siafakas, S. E. Schiza (Heraklion, Greece). CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS). Eur Respir J 2004; 24: Suppl. 48, 3485

Member's Comments

No comment yet.

Related content which might interest you: PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Comparison between subjective and objective measurements in the evaluation of erectile dysfunction in patients with obstructive sleep apnea – hypopnea syndrome (OSAHS) Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002 Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003 Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006 Socioeconomic status and obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Cost estimation of obstructive sleep apnea hypopnea syndrome (OSAHS) diagnosis in Greece Source: Annual Congress 2010 - Influence of delivery of care on outcome parameters: therapy is more than medication prescription Year: 2010 Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome Source: Breathe, 15 (3) e104; 10.1183/20734735.0206-2019 Year: 2019 CPAP and uvulopalatopharyngoplasty (UPPP) normalized pulmonary hypertension in patients with obstructive sleep apnea (OSAS) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Reliability of apnea/hypopnea index (AHI) determined by two different auto-CPAP in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II Year: 2011 Predictors of hypercapnia in obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010 Association between obstructive sleep apnea hypopnea and metabolic syndromes Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004 Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001 NT-proBNP in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006 Prevalence of complex sleep apnea (CompSAS) during manual CPAP titration for obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009